Double-blind, Placebo-controlled Study of Oral Dimebon in Subjects With Mild to Moderate Alzheimer's Disease
NCT00377715 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 183
Last updated 2015-11-11
Summary
This study will evaluate the safety and potential benefit of Dimebon as compared to placebo in patients with mild to moderate Alzheimer's Disease.
Conditions
Interventions
- DRUG
-
Dimebon
- DRUG
Sponsors & Collaborators
-
Medivation, Inc.
lead INDUSTRY
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- QUADRUPLE
- Model
- PARALLEL
Eligibility
- Min Age
- 50 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2005-09-30
- Primary Completion
- 2006-08-31
Countries
- Russia
Study Locations
More Related Trials
-
A Safety and Efficacy Study Evaluating Dimebon (Latrepirdine) in Patients With Moderate to Severe Alzheimer's Disease
NCT00954590 ·Status: TERMINATED ·Phase: PHASE3
-
Safety and Tolerability of Dimebon in Patients on Memantine, and Memantine Plus Donepezil
NCT00829816 ·Status: COMPLETED ·Phase: PHASE1
-
A Phase 1 Study To Evaluate The Pharmacokinetics, Safety, And Tolerability Of Dimebon [PF-01913539] In Japanese And Western Healthy Subjects
NCT00825084 ·Status: COMPLETED ·Phase: PHASE1
-
Efficacy and Safety of DMB-I (INN: Latrepirdine) in Patients With Alzheimer Type Dementia
NCT07251023 ·Status: RECRUITING ·Phase: PHASE3
-
A Study Of Oral PF-01913539 In Patients With Mild To Moderate Alzheimer's Disease
NCT01066481 ·Status: WITHDRAWN ·Phase: PHASE2
-
An Extension To The B1451027 Protocol To Evaluate The Long Term Safety And Tolerability Of Dimebon In Patients With Alzheimer's Disease
NCT00939783 ·Status: TERMINATED ·Phase: PHASE3
-
Study to Evaluate DNL747 in Subjects With Alzheimer's Disease
NCT03757325 ·Status: COMPLETED ·Phase: PHASE1
-
Evaluate the Safety and Efficacy of AD-35 Tablet in Subjects With Mild to Moderate Alzheimer's Disease
NCT03790982 ·Status: UNKNOWN ·Phase: PHASE2
-
Efficacy and Safety of AD-35 in Treatment of Subjects With Mild to Moderate Alzheimer's Disease
NCT03625401 ·Status: UNKNOWN ·Phase: PHASE2
-
A Phase 1, Non-Randomized, Open-Label, Single-Dose Study To Evaluate The Pharmacokinetics, Safety, And Tolerability Of Dimebon [PF 01913539] In Subjects With Severely-Impaired And Normal Renal Function
NCT00824590 ·Status: COMPLETED ·Phase: PHASE1
-
An Extension To The B1451006 Protocol To Evaluate The Safety and Efficacy of Dimebon In Subjects With Moderate-to-Severe Alzheimer's Disease
NCT01066546 ·Status: TERMINATED ·Phase: PHASE3
-
A Phase 1, Randomized, Open-Label, Two-Way Crossover Study To Evaluate The Steady-State Effect Of Dimebon (PF 01913539) On The Single-Dose Pharmacokinetics And Pharmacodynamics Of Warfarin In Healthy Subjects
NCT00827034 ·Status: COMPLETED ·Phase: PHASE1
-
Efficacy and Safety of Dimethyl Fumarate Among Patients with Mild Cognitive Impairment and Dementia Due to Alzheimer's Disease
NCT06850597 ·Status: RECRUITING ·Phase: PHASE2
-
Study of Octohydroaminoacridine Succinate Tablets in Patients With Alzheimer's Disease
NCT01569516 ·Status: UNKNOWN ·Phase: PHASE2
-
The Evaluation of the Efficacy and Safety of Donepezil Hydrochloride in Subjects With Mild Cognitive Impairment (MCI)
NCT00293176 ·Status: COMPLETED ·Phase: PHASE4
-
A Phase 2 Clinical Study to Explore the Optimal Dosage/Administration of PM012 Tablet in Alzheimer's Disease
NCT05811000 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Efficacy Study of MPC-7869 to Treat Patients With Alzheimer's
NCT00105547 ·Status: COMPLETED ·Phase: PHASE3
-
Study to Evaluate the Efficacy and Safety of GSK239512 in Alzheimer's Disease
NCT01009255 ·Status: COMPLETED ·Phase: PHASE2
-
A Study Of PF-04447943 Compared To Placebo In Subjects With Mild To Moderate Alzheimer's Disease
NCT00930059 ·Status: COMPLETED ·Phase: PHASE2
-
Placebo-Controlled Crossover Study to Evaluate Donepezil and MK-3134 for Reversal of Cognitive Impairment Associated With Scopolamine Administration (3134-005)(COMPLETED)
NCT01181310 ·Status: COMPLETED ·Phase: PHASE1
-
Safety and Efficacy Study Evaluating TRx0237 in Subjects With Mild Alzheimer's Disease
NCT01689233 ·Status: COMPLETED ·Phase: PHASE3
-
Study of Combination Therapy With Dimebon and Donepezil (Aricept) in Patients With Alzheimer's Disease
NCT00704782 ·Status: TERMINATED ·Phase: PHASE2
-
Evaluation of E2609 in Subjects With Mild Cognitive Impairment or Mild Dementia Due to Alzheimer's Disease (Study: E2609-A001-101 Amendment 02)
NCT01600859 ·Status: COMPLETED ·Phase: PHASE1
-
24 Months Safety and Efficacy Study of AADvac1 in Patients With Mild Alzheimer's Disease
NCT02579252 ·Status: COMPLETED ·Phase: PHASE2
-
A Multiple Dose Trial of Emraclidine in Elderly Participants and in Participants With Dementia Due to Alzheimer's Disease
NCT05644977 ·Status: COMPLETED ·Phase: PHASE1